Literature DB >> 3678416

Severe alveolar haemorrhage in Churg-Strauss syndrome.

E J Clutterbuck1, C D Pusey.   

Abstract

We report two patients with Churg-Strauss syndrome (CSS), who presented with life-threatening alveolar haemorrhage as the major manifestation of their disease. One improved on high doses of steroids and cyclophosphamide; the other deteriorated on prednisolone alone, but responded rapidly to the addition of cyclophosphamide and plasma exchange. On follow-up, neither showed further evidence of lung disease except for well-controlled asthma. Pulmonary haemorrhage is a well-recognised phenomenon in patients with other forms of systemic vasculitis, and CSS must now be considered in the differential diagnosis of such cases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3678416

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  3 in total

Review 1.  Pulmonary vasculitis: classification, clinical features, and management.

Authors:  A Ciaccia; M Ferrari; F M Facchini; G Caramori; L Fabbri
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

2.  Diffuse alveolar haemorrhage secondary to warfarin therapy for atrial fibrillation: a case report and literature review.

Authors:  Abdelkarim Waness; Tarek Aldabbagh; Mohammed Harakati
Journal:  BMJ Case Rep       Date:  2009-03-17

3.  Congestive cardiomyopathy and endobronchial granulomas as manifestations of Churg-Strauss syndrome.

Authors:  R Alvarez-Sala; C Prados; E Armada; A Del Arco; J Villamor
Journal:  Postgrad Med J       Date:  1995-06       Impact factor: 2.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.